Vijaypd Ceutical Ltd (VIJAYPD) — shareholding pattern, promoter holding, financials and share price
About Vijaypd Ceutical Ltd (VIJAYPD)
Vijaypd Ceutical Ltd operates in the Healthcare Service Provider industry, within the Healthcare sector. It trades on the NSE as VIJAYPD and on the BSE under scrip code 94249. Its ISIN is INE0WL901019.
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services. [1]
Listed peers in Healthcare Service Provider: Vaidya Sane Ayurved Laboratories Ltd, Star Imaging and Path Lab Ltd, Nephro Care India Ltd, Aspira Pathlab & Diagnostics Ltd, Invicta Diagnostic Ltd, Choksi Laboratories Ltd.
Valuation & Returns
10 Jul 2026At ₹70.65 a share on 10 Jul 2026, Vijaypd Ceutical Ltd (VIJAYPD) was valued at a price-to-earnings ratio of 27.49x against an industry P/E of 61.73x and a price-to-book of 2.63x on a book value of ₹26.88 per share. Solomo computes return on equity of 9.53% and return on capital employed of 9.1% from filed results.
- P/E
- 27.49x
- Industry P/E
- 61.73x
- P/B
- 2.63x
- EPS (TTM)
- ₹3.84
- Book value / share
- ₹26.88
- ROE
- 9.53%
- ROCE
- 9.1%
- Debt / equity
- 0.7x
- Dividend yield
- 0%
- 52-week range
- ₹35 – ₹114.5
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Vijaypd Ceutical Ltd (VIJAYPD) reported revenue of ₹100 crore, net profit of ₹5 crore and earnings per share of ₹2.56. Figures are consolidated, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹47.62 crore and net profit ₹2.64 crore (standalone).
| Metric | Mar 2026 |
|---|---|
| Revenue (₹ cr) | 100 |
| Net profit (₹ cr) | 5 |
| EPS (₹) | 2.56 |
| Measure | 1Y |
|---|---|
| Sales growth | 97.77% |
| Profit growth | 190.91% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 56.43% of Vijaypd Ceutical Ltd (VIJAYPD). Market capitalisation was ₹138 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2025.
Largest disclosed public shareholders in Mar 2026: YASH HITESH PATEL 3.5%, YASHVI HITESH PATEL 3.11%, JIGNESH MAHENDRABHAI AJMERA 2.08%, BADAMI NARPATCHAND JAIN 2.07%, PARAS KISHOR AJMERA 1.76%, CHANDRESH KARSONDAS SHAH 1.71%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 56.43% | - | - | - | - |
| Sep 2025 | 78.3% | - | - | - | - |